<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh">
	<id>https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=MLD-41</id>
	<title>MLD-41 - 版本历史</title>
	<link rel="self" type="application/atom+xml" href="https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=MLD-41"/>
	<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=MLD-41&amp;action=history"/>
	<updated>2026-07-16T02:24:50Z</updated>
	<subtitle>在这个wiki上该页的修订历史</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://arolstar52-zhtest.hf.space/index.php?title=MLD-41&amp;diff=4522080&amp;oldid=prev</id>
		<title>imported&gt;Nucleus hydro elemon 来自 2025年9月10日 (三) 23:08</title>
		<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=MLD-41&amp;diff=4522080&amp;oldid=prev"/>
		<updated>2025-09-10T23:08:48Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新页面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Drugbox&lt;br /&gt;
| Watchedfields = changed&lt;br /&gt;
| verifiedrevid = 447572878&lt;br /&gt;
| IUPAC_name = (8β)-&amp;#039;&amp;#039;N&amp;#039;&amp;#039;,&amp;#039;&amp;#039;N&amp;#039;&amp;#039;-Diethyl-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide&lt;br /&gt;
| image = MLD-41.svg&lt;br /&gt;
| width =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename = &lt;br /&gt;
| legal_AU = &lt;br /&gt;
| legal_CA = &lt;br /&gt;
| legal_UK = &lt;br /&gt;
| legal_US = &lt;br /&gt;
| routes_of_administration = [[口服]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| metabolism = 肝&lt;br /&gt;
| excretion = 肾&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|??}}&lt;br /&gt;
| CAS_number = 4238-85-1&lt;br /&gt;
| PubChem = 165200&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}&lt;br /&gt;
| ChemSpiderID = 144824&lt;br /&gt;
| synonyms = N1-甲基麦角酸二乙酰胺&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=21 | H=27 | N=3 | O=1 &lt;br /&gt;
| SMILES = O=C(N(CC)CC)[C@@H]3/C=C2/c4cccc1c4c(cn1C)C[C@H]2N(C3)C&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C21H27N3O/c1-5-24(6-2)21(25)15-10-17-16-8-7-9-18-20(16)14(12-22(18)3)11-19(17)23(4)13-15/h7-10,12,15,19H,5-6,11,13H2,1-4H3/t15-,19-/m1/s1&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChIKey = VQZYKSWQIQANKB-DNVCBOLYSA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;{{PAGENAME}}&amp;#039;&amp;#039;&amp;#039;（N1-Methyl-lysergic acid diethylamide，N1-甲基-麦角酸二乙酰胺）是一种[[有机化合物]]，化学式为[[C21H27N3O|C&amp;lt;sub&amp;gt;21&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;27&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;O]]，为[[迷幻药物]][[麥角酸二乙酰胺]]（LSD）的[[同系物]]，与LSD存在交叉耐受性&amp;lt;ref&amp;gt;{{cite journal | vauthors = Abramson HA, Rolo A, Sklarofsky B, Stache J | title = Production of cross-tolerance to psychosis-producing doses of lysergic acid diethylamide and psilocybin. | journal = The Journal of Psychology | date = January 1960 | volume = 49 | issue = 1 | pages = 151–4 | doi = 10.1080/00223980.1960.9916396 }}&amp;lt;/ref&amp;gt;。&lt;br /&gt;
&lt;br /&gt;
==参考文献==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:麦角酰胺]]&lt;/div&gt;</summary>
		<author><name>imported&gt;Nucleus hydro elemon</name></author>
	</entry>
</feed>